Evidence map›Paper›PMID 41843600›Full record

ArticlePloS one2026

Evaluation of a commercial AI-assisted cell counting software for dopaminergic neurons across species.

Ken Kunugitani, Masanori Sawamura, Tomoyuki Taguchi, Tetsuya Hirato, Norihito Uemura, Takashi Ayaki, Etsuro Nakanishi, Hodaka Yamakado, Tomoyuki Ishimoto, Hirotaka Onoe and 3 more

Abstract readEvaluation Study
In one paragraph

Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ken KunugitaniDepartment of Pharmacology, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0009-0008-3415-7264
Masanori SawamuraDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0000-0002-9613-6230
Tomoyuki TaguchiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tetsuya HiratoDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Norihito UemuraDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Takashi AyakiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Etsuro NakanishiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.ORCID https://orcid.org/0009-0006-9869-4988
Hodaka YamakadoDepartment of therapeutics for Multiple System Atrophy, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tomoyuki IshimotoDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Hirotaka OnoeHuman Brain Research Center, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Tadashi IsaDepartment of Physiology and Neurobiology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Riki MatsumotoDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.
Ryosuke TakahashiDepartment of Neurology, Kyoto University Graduate School of Medicine, Kyoto, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Quantification of dopaminergic neurons in the substantia nigra pars compacta (SNc) of animal models is important for understanding the pathogenesis of Parkinson's disease (PD). However, conventional manual cell counting method requires the time and effort, and has limited reproducibility due to inter- and intra-examiner variability. Here, we demonstrate that a commercially available convolutional neural network-based artificial intelligence (AI) counting method (TruAI, OLYMPUS, Tokyo, Japan) enables robust and reproducible quantification of TH-positive dopaminergic neurons in mouse, marmoset, and human SNc samples when compared with conventional manual counting. AI-based counting showed a strong correlation with manual counting across mouse, marmoset, and human samples. Good agreement between AI-based and manual counting was observed in mouse and marmoset samples, supporting the applicability of this approach for cross-species quantification of dopaminergic neurons. In the mouse model treated with α-syn preformed fibrils (PFFs), AI-based counting detected a significant reduction in TH-positive neurons consistent with expert manual counting. Non-experts exhibited greater intra-examiner variability than an expert, indicating that the reliability of manual counting depends on experience. Overall, AI-based quantification provides a robust and objective approach for TH-positive cell counting and may improve reproducibility in dopaminergic neuron analysis, particularly for non-expert users and cross-species studies of PD.

Indexed as

Artificial IntelligenceDopaminergic NeuronsSoftwareAnimalsCallithrixCell CountConvolutional Neural NetworksHumansMiceParkinson DiseasePars CompactaReproducibility of ResultsSpecies Specificity

Identifiers

PMID41843600
PMCPMC12994822

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.